RBC Capital Markets has pushed back against short sellers who argue that Bloom Energy's growth is constrained by its reliance on scandium, a rare metal used in some of its fuel-cell components. In a note to clients this week, the Canadian bank said that a review of Bloom's recent patents and regulatory filings suggests the company has found ways to reduce its dependence on the metal, potentially lifting a key overhang on the stock.
The Scandium Debate
Short sellers have focused on scandium as a potential bottleneck for Bloom Energy, which produces solid-oxide fuel cells that convert natural gas or hydrogen into electricity. Scandium is a rare-earth element that is difficult to source in large quantities, and critics argue that its scarcity could limit how many fuel-cell systems Bloom can produce. That would force analysts to assume slower long-term growth and assign a larger "supply risk" discount to the company's valuation.
RBC pushed back on two fronts. First, the bank said that the short reports rely on older technical references, while Bloom's newer patents, regulatory filings, and related academic work point to designs that likely use less scandium. Second, RBC argued that even if demand for Bloom's systems jumps, suppliers have enough lead time to expand output, making availability a planning problem rather than an insurmountable barrier.
What It Means for Investors
When investors believe a key material is truly scarce, they don't just shave next quarter's sales estimates. They often assume the business cannot scale indefinitely, which lowers the long-run growth baked into valuation models and hits the "terminal value"—the estimated value of a company beyond a forecast period—the hardest. RBC's read of patents and filings as signaling reduced scandium intensity is meant to lift that perceived ceiling and shrink the supply-constraint discount.
If that view holds, Bloom's valuation becomes less hostage to commodity-supply fears and more sensitive to the usual drivers: manufacturing ramps, customer orders, and the pace at which the company turns its backlog into delivered products. RBC reiterated an "outperform" rating and a $335 per-share price target, effectively saying the scandium debate should matter less than execution.
Broader Context
The debate over Bloom's supply chain comes at a time when energy stocks are getting a boost from rising oil prices, with crude surging past $80 and BP warning of a $1 billion charge. Meanwhile, the broader clean-energy sector is seeing activity, including a $1.8 billion clean-energy deal in India and a $2 billion US bank merger. Bloom's fuel-cell technology sits at the intersection of energy and tech, and its ability to scale without supply constraints could determine whether it captures a share of the growing market for distributed power generation.
Investors will be watching for updates on Bloom's production capacity, delivery timelines, and backlog growth. If RBC's analysis proves correct, the stock could become more responsive to operational milestones rather than raw-material fears. But if short sellers' concerns linger, the supply-risk discount may persist, keeping a lid on the stock's multiple.
What to Watch Next
For everyday investors, the key takeaway is that the scandium debate is not just about one mineral—it's about whether Bloom's growth story is real or capped. RBC's $335 price target hinges on the assumption that scandium is a manageable issue, not a permanent bottleneck. As the company reports future earnings and provides updates on its manufacturing ramp, the market will get a clearer picture of whether the bank's view is right.
In the meantime, the broader market is digesting mixed signals. Goldman Sachs and UBS are predicting rare negative US inflation in June as energy costs fall, which could shift the macro backdrop for growth stocks like Bloom. And Meta's $50 billion AI pledge failed to lift chip stocks as Google's in-house chips raised doubts about Nvidia, highlighting how supply-chain and technology debates can ripple across sectors.
